Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:e12
doi: 10.1161/CIRCRESAHA.108.179614
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valdivia, H. H.
Right arrow Articles by Houser, S. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Valdivia, H. H.
Right arrow Articles by Houser, S. R.
(Circulation Research. 2008;103:e12.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Response to Mattiazzi et al:

Héctor H. Valdivia

Department of Physiology, University of Wisconsin Medical School, Madison, WI

Steven R. Houser

Department of Physiology, Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pa, E-mail steven.houser@temple.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Our recent article in Circulation Research1 has received attention from a number of investigators in the field. Our goal in this research was to explore the hypothesis proposed by Marks and colleagues that PKA-mediated phosphorylation of the ryanodine receptor at Ser2808/09 is a central component of the sympathetic nervous system (SNS) regulation of cardiac contractility.2 Our experiments were mainly designed to address this issue. We used a genetically modified mouse in which phosphorylation of Ser2808/09 was eliminated by an alanine substitution (S2809/09A). Our results strongly supported the idea that PKA-mediated phosphorylation of Ser2808/09 has no significant functional role in SNS regulation of cardiac function.

In this issue of Circulation Research, Mattiazzi et al3 have written to the editor regarding our recent report.1 The purpose of our letter here is to respond to the 3 points made by Mattiazzi et al.3 First, we all agree that there is significant evidence that phosphorylation of Ser2808/09, either by PKA,2,4 or by CaMKII,5,6 has little functional significance in the response of the heart to sympathetic stimulation. As we reviewed in our recent report,1 many laboratories are in agreement on this issue, including Mattiazzi and colleagues,6 and this was the major conclusion of our report.

Mattiazzi et al3 point out that there appear to be other PKA phosphorylation sites on RyR2 and that these may have functional significance. Our recent study did not evaluate this possibility; however, Valdivia and colleagues, coauthors in the recent by MacDonnell et al,1 have been actively involved in this . . . [Full Text of this Article]